Frankincense oil derived from Boswellia carteri induces tumor
cell specific cytotoxicity
[View abstract at:
http://www.biomedcentral.com/1472-6882/9/6/abstract]
Mark Barton Frank, Qing Yang ,Jeanette Osban, Joseph T Azzarello, Marcia R Saban,
Ricardo Saban, Richard A Ashley, Jan C Welter, Kar-Ming Fung and Hsueh-Kung Lin
BMC Complementary and Alternative Medicine 2009, 9:6doi:10.1186/1472-6882-9-6
Published: 18 March 2009
Abstract (provisional)
Background
Originating from Africa, India, and the Middle East, frankincense oil has been
important both socially and economically as an ingredient in incense and
perfumes for thousands of years. Frankincense oil is prepared from aromatic
hardened gum resins obtained by tapping Boswellia trees. One of the main
components of frankincense oil is boswellic acid, a component known to have
anti-neoplastic properties. The goal of this study was to evaluate frankincense
oil for its anti-tumor activity and signaling pathways in bladder cancer cells.
Method
Frankincense oil-induced cell viability was investigated in human bladder cancer
J82 cells and immortalized normal bladder urothelial UROtsa cells. Temporal
regulation of frankincense oil-activated gene expression in bladder cancer cells
was identified by microarray and bioinformatics analysis.
Results
Within a range of concentration, frankincense oil suppressed cell viability in
bladder transitional carcinoma J82 cells but not in UROtsa cells. Comprehensive
gene expression analysis confirmed that frankincense oil activates genes that
are responsible for cell cycle arrest, cell growth suppression, and apoptosis in
J82 cells. However, frankincense oil-induced cell death in J82 cells did not
result in DNA fragmentation, a hallmark of apoptosis.
Conclusion
Frankincense oil appears to distinguish cancerous from normal bladder cells and
suppress cancer cell viability. Microarray and bioinformatics analysis proposed
multiple pathways that can be activated by frankincense oil to induce bladder
cancer cell death. Frankincense oil might represent an alternative intravesical
agent for bladder cancer treatment.